Market revenue in 2023 | USD 20.3 million |
Market revenue in 2030 | USD 35.6 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Phase iii |
Fastest growing segment | Phase I |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Key market players worldwide | Thermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 57.14% in 2023. Horizon Databook has segmented the Spain clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
Spain is ranked as one of the top countries in the number of clinical trials performed. The country is a highly desirable location for conducting clinical trials as it is known as an innovation & knowledge hub with highly coordinated research centers, specialized clinical trial hospitals, and experienced investigators.
In 2020, FarmaIndustria stated that Spain was the fourth-largest country in the world in clinical trials for COVID-19 drugs. According to the latest R&D activities survey conducted by Farmaindustria, the pharmaceutical industry in Spain demonstrates a strong commitment to clinical trials.
This industry promotes eight out of ten clinical trials and allocates 60% of its total investment in research and development to develop new medicines in this field. In 2019, USD 1,328.1 million was invested, with USD 781.9 million specifically dedicated to clinical trials.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain clinical trial patient recruitment services market , including forecasts for subscribers. This country databook contains high-level insights into Spain clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account